FdaApplication
NDA 021881
Identifiers
- fda_app_no: NDA021881
Properties
| Property | Value |
|---|---|
| applicant_name | SALIX PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2006-08-02 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| MOVIPREP | ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE | 4.7GM;100GM;1.015GM;5.9GM;2.691GM;7.5GM | FOR SOLUTION;ORAL |
1 product